Abstract: Aspirin resistance can be defined as the inability of the usual dose of aspirin medication to produce its antithrombotic effect. Patients with diabetes or cardiovascular disease are at higher risk of stroke, myocardial infarction or cardiovascular death due to aspirin resistance. The aim of this bibliometric study was to identify and analyse the status and trends of aspirin resistance research production at global level through publications indexed in the Scopus database; this will shed new light on future research trends and help researchers predict dynamic direction of research. Literature search using the Scopus database was conducted to assess publications related to aspirin resistance. The selected publications included the terms related to aspirin resistance in the title, abstract or keywords. The searching was accomplished on 20 March 2016 and can be considered to include all publications up to 31 December 2015. Global cumulative publication output on aspirin resistance consists of 986 papers during 1990-2015. Among the 986 documents, 19 (1.9%) were published before 2000, 567 (57.5%) were published from 2000 to 2009 and 400 (40.6%) were published from 2010 to 2015, with peak of publications on this topic in 2008. The leading country in the field of aspirin resistance was the United States, which had the greatest counts of independent articles (165) and international collaboration articles (44). Turkey was in the second rank with 78 articles, followed by Italy (68), the UK (62) and Poland (60). The total number of citations for all documents was 26,342, and the average citations per document were 26.7. The h-index for all aspirin resistance publications was 82. This study presents the results of the first bibliometric study (including quantitative and qualitative analysis) of scientific publications in the field of aspirin renitence at global level. Aspirin resistance-related researches have notably increased in the last years, especially from 2000 to 2015. The United States is the most prolific country, not only in research quantity but also in quality. Furthermore, Turkey and European countries provided more research related to aspirin resistance than other regions such as the developing countries.
Aspirin resistance can be defined as the inability of the usual dose of aspirin medication to produce its antithrombotic effect. Previous studies found that 5 to 60 per cent of patients do not respond to aspirin as a medication of secondary prevention of ischaemic diseases [1, 2] . Aspirin resistance can be identified at clinical and laboratory levels [3, 4] . Laboratory aspirin resistance can be defined as the failure of aspirin to inhibit thromboxane A2 synthesis or the failure of platelet aggregation that depends on thromboxane A2 production. In addition, failure of aspirin to prevent atherosclerosis and ischaemic events refers to clinical aspirin resistance [1, 3] .
Patients with diabetes or cardiovascular disease are at higher risk of stroke, myocardial infarction or cardiovascular death due to aspirin resistance [5] [6] [7] [8] [9] . Possible causes of aspirin resistance include drug-drug interactions, insufficient dose, up-regulation of thromboxane synthesis from non-platelet sources, genetic variability of cyclooxygenase-1, increased platelet turnover and variability in enzyme induction that affects the drug metabolism [1, 2, [10] [11] [12] [13] [14] [15] [16] [17] [18] .
Although there are few published bibliometric studies in the field of cardiology internationally [19] [20] [21] [22] [23] , there is a lack of studies that focused on assessment of scientific research output related to aspirin resistance. A common research instrument is based on bibliometric techniques that have previously been commonly used in studies on assessment of scientific research output and research trends in many health disciplines [22, [24] [25] [26] [27] [28] . Bibliometric analysis uses quantitative and qualitative analysis of scientific output within a given field, journal, country, etc. [24, [29] [30] [31] [32] [33] [34] [35] .
The aim of this bibliometric study was to identify and analyse the status and trends of aspirin resistance research production at global level through publications indexed in the Scopus database; this will shed new light on future research trends and help researchers predict dynamic direction of research.
Methods
A literature search using the Scopus database was conducted to assess publications related to aspirin resistance on 20 March 2016. This database was chosen as it combines the characteristics of both the PubMed and Web of Science databases [36, 37] , and it is the most important and commonly used database for broad evaluation of scientific research activities in all fields [36] [37] [38] [39] . The current study was performed based on previous similar bibliometric publications [25] [26] [27] [28] 40] . The selected publications included the following terms in the title, abstract or keywords: 'aspirin resistance' or 'aspirin-resistant' or 'acetylsalicylic acid resistance' or 'resistance to acetylsalicylic' or 'resistance to aspirin' or 'resistance to ASA' or 'salicylate resistance' or 'ASA resistance' or 'aspirin failure' or 'failure of aspirin treatment' or 'aspirin treatment failure' or 'aspirin non-responsiveness' or 'aspirin Author for correspondence: Samah W. Al-Jabi, Department of Clinical and Community Pharmacy, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus 44839, Palestine (e-mail samahjabi@yahoo.com). non-responsiveness' or 'aspirin non-response'. These terms were selected from the related previous studies to aspirin resistance [41] [42] [43] [44] . Exclusion criteria were any publications not relevant to aspirin resistance.
The searching was accomplished on 20 March 2016 and can be considered to include all publications up to 31 December 2015 to assess the following aspects: publication output, publication type, language of publication, country of publication with h-index, internationally collaborative publications, citation patterns, distribution of journals, impact factors (IFs) and distribution of institutions. Furthermore, the top 10 prolific countries, journals, institutes and the top 10 most frequently cited publications about aspirin resistance in the Scopus database were also discussed. Here, the results are ranked according to their productivity using a Standard Competition Ranking (SCR) scheme (i.e. '1224' ranking) [25, 28, 40] . Two of the most popular indicators for qualitative analysis are h-index and IFs which were used to measure the scientific research performance in the field of aspirin resistance. IFs were obtained according to the Journal Citation Reports (JCR) 2014 [45] . The h-index can more perfectly replicate the country's or field's achievement; a higher h-index shows the country's or field's larger influential power [46] .
Ethical issues.
Because this bibliometric analysis used only published data in the secondary database, no approval from our institutional review board (IRB) was required.
Data analysis. The extracted data were organized and analysed using Microsoft Excel version 2003 and the Statistical Package for the Social Sciences (SPSS) software version 15.0 so as to obtain frequencies, percentages, averages or figures. A further comprehensive analysis was performed for the publications of the main prolific countries including the total number of publications adjusted for the development indices of countries (population size and gross domestic product (GDP) retrieved from the online databases of the World Bank [47] ), and data associated with stroke and heart diseases (disabilityadjusted life year (DALYS) loss rate and number of deaths retrieved from the online databases of the World Health Organization [48] ). The statistical significance of the correlations between number of publications and the development indices of countries, and data associated with stroke and heart diseases were determined by Pearson's correlation coefficient test, and p < 0.05 was considered significant.
Results
Global cumulative publication output on aspirin resistance consists of 986 papers during 1990-2015, which works out to an average annual productivity of 37.9 papers. Major document types included Article (597, 60.5%), Review (205, 20.8%), Letter (70, 7.1%) and Note (31, 3.1%). The remaining publications (83, 8 .3%) were book reviews, editorial and conference paper. The annual number of the publications associated with aspirin resistance research during 1990-2015 is shown in fig. 1 .
Among the 986 documents, 19 (1.9%) were published before 2000, 567 (57.5%) were published from 2000 to 2009 and 400 (40.6%) were published from 2010 to 2015, with peak of publications on this topic in 2008 (126, 12.8%). There were nineteen languages in use. English (835), as the most popular language, comprised 84.7% of the total publications, followed by Chinese (28), French (22) , German (22) and Polish (20) .
These publications were published from 59 countries. Table 1 shows the top 10 countries with the highest research productivity in the field of aspirin resistance and shows their total number of publications, h-index for these countries and international collaboration articles. The leading country in the field of aspirin resistance was the United States, which had the greatest counts of independent articles (165) and international collaboration articles (44) . Turkey was in the second rank with 78 articles, followed by Italy (68), the UK (62) and Poland (60) . The total number of citations for all documents was 26,342, and the average citations per document were 26.7. The h-index for all aspirin resistance publications was 82. The h-index for publications from the United States ranked the first out of the 10 most productive countries (h-index value = 47), followed by Italy (h-index value = 26), the UK (h-index value = 21) and Germany (h-index value = 21). Table 2 shows the publications number and development indices of countries, and data associated with stroke and heart disease for the top 10 most prolific countries in the field of aspirin resistance. No significant correlation was found between the country population size and the number of publications (r = 0.080, p = 0.825). There was a moderate positive correlation between number of publications and 2015 GDP values of the top 10 most prolific countries in the field of aspirin resistance (r = 0.802, p = 0.005). On the other hand, there was no correlation between stroke DALYS loss rates or deaths related to stroke and number of aspirin resistance publications (r = 0.001, p = 0.999; and r = À0.042, p = 0.907, respectively). Furthermore, there was no correlation between heart DALYS loss rates or deaths related to heart disease and number of aspirin resistance publications (r = 0.287, p = 0.422; and r = À0.494, p = 0.146, respectively).
The publications related to aspirin resistance were published in 461 journals. The top 10 most prolific journals in the field of aspirin resistance are presented in table 3. Thrombosis Research published the most articles (40 documents), followed by Journal of the American College of Cardiology (31 documents) and Thrombosis and Haemostasis (28 documents). Combined together, these 10 most prolific journals were responsible for 23.5% (243/986) of the total research output related to aspirin resistance. Thrombosis Research ranked the first in the list of 10 most prolific journals with impact factor of 2.447. Journal of the American College of Cardiology ranked the second in the list of 10 most prolific journals with the highest impact factor of 16.503. Blood Coagulation and Fibrinolysis ranked the seventh in the list of 10 most prolific journals with the lowest impact factor of 1.403. Table 4 includes the 10 most cited publications related to aspirin resistance [5, 41, [49] [50] [51] [52] [53] [54] [55] [56] . The number of citations for the top 10 cited articles ranged from 377 to 860. The IFs for journals with the top 10 cited articles related to aspirin resistance ranged from 2.447 to 17.445. Three of them were published in Journal of the American College of Cardiology, and two of them were published in Circulation. The two articles that achieved the most citations were published by Eikelboom et al. Furthermore, in the top 10 most prolific institutes, there are three institutes in the United States, two in Poland and one each in Turkey, Canada, Germany, the UK, Croatia, France and Italy. It is worth noting that the top 10 countries with the highest research productivity in the field of aspirin resistance were found in the top most productive institutes.
Discussion
The current study has revealed several characteristics related to aspirin resistance research: the progressive growth related to aspirin resistance at global level; the publication of this topic in a wide variety of journals; and the research led by Western countries, most noticeably the United States, European countries and Canada. The current study showed that the annual number of the publications related to aspirin resistance research during 1990-2015 is highly variable and fluctuating. For example, there is a rise in the number of publications from 9 publications in 2000 to 126 articles in 2008; however, the number declines to 42 articles in 2015. This increase in publications may be associated with rapidly rising prevalence of aspirin resistance and higher interest in this field from multiple disciplines [41, 42, [57] [58] [59] [60] . Furthermore, the rise in the number of publications may have been caused by the articles published in 2006 and 2007 [2, 13, 16, 56, [61] [62] [63] [64] [65] [66] [67] [68] [69] which discussed the clinical entities due to aspirin resistance which may potentially lead to serious clinical outcome, such as recurrent myocardial infarction, cerebrovascular accident or death. These The United States was the most prolific country in producing articles related to aspirin resistance, contributing to 21.2% of the publications. This research output from the United States is possibly due to the economic strength, nation's large size and numerous large academic or research medical centres [70] . Furthermore, European countries provided more scientific research related to aspirin resistance than other regions such as the developing countries. This was due to the long tradition, rich financial support, excellent research institutions [71] and sound basis of aspirin resistance research in Western Europe. What is inspiring is that the contribution of countries such as Turkey played a bigger role in producing articles related to aspirin resistance. Several studies conducted in Turkey reported a high frequency of aspirin resistance in patients with kidney failure [72, 73] , acute coronary syndrome [74] [75] [76] , hypertension [77] , chest pain [78] , metabolic syndrome [79, 80] , diabetes mellitus [81] , stroke [76] , systemic lupus erythematosus [82] and cigarette smoking [83] . These results might open the door for new ideas and questions for research related to aspirin resistance.
Although the publications from international collaborations predominated was evident. International collaboration research is necessary to address priorities in research and to obtain funding [84] , with the ultimate objective of accelerating research productivity and the development of antiplatelet therapy to prevent cardiovascular diseases (primary prevention) and to treat acute or chronic diseases (secondary prevention) [85] [86] [87] .
The current study ranked and characterized the top 10 cited publications related to aspirin resistance. This evaluation presents, for the first time, very useful insight into the progress of popular opinion in the field of aspirin resistance that has undergone substantial change over the years. Without a doubt, Eikelboom et al. [5] had a fundamental influence in the aspirin resistance literature. The most influential article in aspirin resistance was written by Eikelboom and experts from Canada and Australia [5] and was published in 2002 in Circulation. This article described an increased risk of stroke, myocardial infarction or cardiovascular death related to aspirin resistance as found by urinary elevation of 11-dehydro-thromboxane B2 level in patients with diabetes or cardiovascular disease [5] . The second most frequently cited article by Gum et al. [49] was published in 2003 as a prospective cohort Table 2 . Publication numbers and development indices of countries, and data associated with stroke and heart disease data for the top 10 most prolific countries in the field of aspirin resistance. [49] . Although this is the first bibliometric study to estimate global trends in aspirin resistance-related research, several limitations of this study should be addressed. Firstly, the search was conducted on 20 March 2016 and considered to include all publications up to 31 December 2015, and thus, 2015 was included in the analysis as database entries would have been still open for new data related to 2015. Secondly, the publications included in the bibliometric analysis were those in which 'aspirin resistance' and related terms appeared in the title, abstract or keywords. However, some publications in which 'aspirin resistance' and its related terms were stated inside their text were not retrieved for analysis. Excluding these few publications, that their scope is not related to aspirin resistance, is unlikely to influence the overall results. Thirdly, because this bibliometric search was limited to Scopus-indexed journals, publications in journals not indexed in the Scopus database were missed. All of these limitations were reported in other bibliometric studies [35, [88] [89] [90] [91] .
Conclusions
This study presents the results of the first bibliometric study (including quantitative and qualitative analysis) of scientific publications in the field of aspirin resistance at global level. Aspirin resistance-related researches have notably increased in the last years, especially from 2000 to 2015. The United States is the most prolific country, not only in research quantity but also in quality. Furthermore, Turkey and European countries provided more scientific research related to aspirin resistance than other regions such as the developing countries. Overall, this study has also shown the trends and characteristics of aspirin resistance research and provided a helpful guide for researchers in the field of aspirin resistance in planning and managing their research topics.
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